Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.4% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

Enrollment reporting

Analytics

N/A
6(100.0%)
6Total
N/A(6)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT07905755Not ApplicableNot Yet Recruiting

Effect of HMB Supplementation and Vivifrail Exercise on Body Composition, Handgrip Strength and Physical Performance in Women Over 60 Years of Age

Role: lead

NCT07874958Not ApplicableCompleted

"AFRONTA Emotional Care" Intervention for Family Caregivers of Children With Cancer.

Role: collaborator

NCT07531888Not ApplicableEnrolling By Invitation

Effects of tDCS on Cognitive Function in Older Adults With Subjective Cognitive Decline: Randomized Sham-Controlled Trial

Role: lead

NCT07359729Not ApplicableCompleted

Deep Breathing and Virtual Reality for Venipuncture Pain

Role: lead

NCT07017296Not ApplicableCompleted

Microencapsulated Pomegranate Juice as Anti-Hypertensive

Role: lead

NCT03531749Not ApplicableCompleted

Antioxidant in Patients HIV+ Supplemented With Microencapsulated of Red Pomegranate

Role: lead

All 6 trials loaded